Arrowhead Pharmaceuticals Names Daniel Apel Chief Financial Officer

, MT Newswires -  4:28 PM ET 4/15/2025 Company News

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print

04:28 PM EDT, 04/15/2025 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said late Tuesday it has appointed Daniel Apel as its chief financial officer, effective May 13, succeeding Ken Myszkowski, who will retire.

Myszkowski will continue to offer his services as an employee adviser to ensure a smooth transition, the company said.

Apel previously worked as global head of financial planning and analysis at Walgreens Boots Alliance ( WBA ) , Arrowhead said.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

© 1999-2025 Midnight Trader, Inc. All rights reserved.

  • Facebook.
  • Twitter.
  • LinkedIn.
  • Print
close
Please enter a valid e-mail address
Please enter a valid e-mail address
Important legal information about the e-mail you will be sending. By using this service, you agree to input your real e-mail address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an e-mail. All information you provide will be used by Fidelity solely for the purpose of sending the e-mail on your behalf.The subject line of the e-mail you send will be "Fidelity.com: "

Your e-mail has been sent.
close

Your e-mail has been sent.